Vaxine, a South Australian biotechnology company has developed a protein based vaccine against Covid-19. The company’s Covax-19 is currently in advanced clinical trials. Vaxine has lobbied for the South Australian Government to recognise Covid-19 trial participants as exempted from needing a TGA approved vaccine, and the company today announced the exemption has been granted.
This comes after news that the creator of Covax-19, Flinders Professor Nikolai Petrovsky, was at risk of losing his job after he administered his own vaccine on himself rather than receiving one of the TGA approved vaccines. Making him unable to comply with SA Health’s vaccine mandate at the time. “It would be a little unusual if we were to have someone else’s vaccine rather than the one we developed ourselves” he said.
Sharen Petrovsky, who successfully organised a crowd fundraiser to raise money for the vaccine to be submitted for TGA approval said ” The previous refusal to recognise trial subjects was unfair and extremely damaging to SA’s reputation as a place to do trials”.
SA Health has also made a concession for health workers that if they have an appointment to be assessed by a medical specialist or have started an assessment to determine if they have a medical exemption, then they do not require evidence of vaccination to work.
Sharen Petrovsky has also stated they are now lobbying SA health to recognize GP-submitted vaccine exemptions.